CONX Corp.

CONX Corp. is a blank check company. Its purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets. The company was founded by Charles William Ergen on August 26, 2020 and is headquartered in Littleton, CO.

Corgenix Medical Corporation is engaged in the research, development, manufacture, and marketing of in vitro diagnostic (IVD) products for use in disease detection and diagnosis in North America and internationally. It provides ELISA tests; vascular disease products, such as antiphospholipid antibody testing products; and products that are used in the diagnosis of bleeding and clotting disorders, including von Willebrand’s disease (hemophilia B). The company also provides the AspirinWorks test kit, a urine test that measures aspirin dosage; and liver disease products. In addition, it offers contract manufacturing services to other diagnostic and life science companies, as well as contract product development services to strategic partners and alliances; and purchases and resells IVD products, instruments, instrument systems, and various reagents and supplies. The company manufactures and sells approximately 50 diagnostic products to hospitals, clinical testing laboratories, universities, biotechnology and pharmaceutical companies, and research institutions through a network of sales representatives, independent distributors, and private label agreements. Corgenix Medical Corporation has a strategic collaboration with Tulane University, and other industry and academic partners to develop a group of products to detect viruses identified as potential bio-terrorism agents. The company was founded in 1985 and is headquartered in Broomfield, Colorado.

LITTLETON, Colo. , May 1, 2024 /PRNewswire/ -- CONX Corp. (Nasdaq: CONX) (the "Company" or "CONX"), completed its previously announced transaction pursuant to the terms of the purchase and sale agreement (as amended by that amendment to the sale and purchase agreement, the "Purchase Agreement"), dated as of March 10, 2024, by and between the Company and EchoStar Real Estate Holding L.L.C.

CONX Corp. Announces Closing of Initial Business Combination

LITTLETON, Colo. , April 29, 2024 /PRNewswire/ -- CONX Corp. (Nasdaq: CONX) (the "Company" or "CONX") announced today the final results of its previously announced tender offer (the "Tender Offer") to purchase up to 2,120,269 of its shares of Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), at a purchase price of $10.598120 per share.

CONX Corp. Announces Final Tender Offer Results

LITTLETON, Colo. , April 15, 2024 /PRNewswire/ -- CONX Corp. (Nasdaq: CONX) (the "Company" or "CONX") announced today that it has changed the price to be paid in its previously announced tender offer (the "Tender Offer") to purchase up to 2,120,269 of its shares of Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), to $10.598120 per share (the "Purchase Price").

CONX Corp. Announces Change in Tender Offer Price to Complete Business Combination

LITTLETON, Colo. , April 1, 2024 /PRNewswire/ -- CONX Corp. (Nasdaq: CONX) (the "Company" or "CONX") announced today that it has commenced a tender offer (the "Tender Offer") to purchase up to 2,120,269 of its shares of Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), at a purchase price of $10.585614 per share (the "Purchase Price").

CONX Corp. Announces Tender Offer to Complete Business Combination

DISH Network

Blank-check firm CONX Corp , backed by Dish Network Corp Chairman Charles Ergen, said on Wednesday it has begun preliminary discussions to acquire Dish's retail wireless unit, Boost Mobile.

Dish Network chairman-backed SPAC in talks to buy wireless business unit

LITTLETON, Colo. , Oct. 12, 2022 /PRNewswire/ -- CONX, Corp. (Nasdaq: CONX, CONXU, CONXW) ("CONX" or the "Company") encourages stockholders to vote in favor of the proposal to amend CONX's articles of incorporation (the "Extension Amendment") to extend the date by which the Company must complete a business combination from November 3, 2022 to June 3, 2023 (the "Extension").

CONX Files Proxy Statement for Stockholders to Vote on Extension of Completion Period; Discloses Preliminary Discussions Regarding Business Combination

News for CONX Corp. Stock (CONX)